IL-17 and IL-22 have been shown to increase protection against certain bacteria and fungal pathogens in experimental models. However, no human studies have demonstrated a crucial role of IL-17 and IL-22 in protection against infections. We show here that Leishmania donovani, which can cause the lethal visceral disease Kala Azar (KA), stimulates the differentiation of Th17 cells, which produce IL-17, IL-22, and IFN-γ. Analysis of Th1, Th2, and Th17 cytokine responses by cultured PBMCs from individuals in a cohort of subjects who developed KA or were protected against KA during a severe outbreak showed that IL-17 and IL-22 were strongly and independently associated with protection against KA. Our results suggest that, along with Th1 cytokines, IL-17 and IL-22 play complementary roles in human protection against KA, and that a defect in Th17 induction may increase the risk of KA.
Maira G.R. Pitta, Audrey Romano, Sandrine Cabantous, Sandrine Henri, Awad Hammad, Bouréma Kouriba, Laurent Argiro, Musa el Kheir, Bruno Bucheton, Charles Mary, Sayda Hassan El-Safi, Alain Dessein
Title and authors | Publication | Year |
---|---|---|
Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice
RS Gomes, MV Silva, JC dos Santos, C van Linge, JM Reis, MM Teixeira, SA Pinto, ML Dorta, X Bai, ED Chan, CA Dinarello, MA Oliveira, LA Joosten, F Ribeiro-Dias, JA Appleton |
Infection and immunity | 2018 |
Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
CI Brodskyn, S Kamhawi |
Frontiers in Cellular and Infection Microbiology | 2018 |
Lutzomyia longipalpis Saliva Drives Interleukin-17-Induced Neutrophil Recruitment Favoring Leishmania infantum Infection
CR Teixeira, C da S. Santos, DB Prates, RT dos Santos, T Araújo-Santos, SM de Souza-Neto, VM Borges, M Barral-Netto, CI Brodskyn |
Frontiers in microbiology | 2018 |
The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection
Y Li, C Wei, H Xu, J Jia, Z Wei, R Guo, Y Jia, Y Wu, Y Li, X Qi, Z Li, X Gao |
Mediators of Inflammation | 2018 |
Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
W Adriaensen, TP Dorlo, G Vanham, L Kestens, PM Kaye, J van Griensven |
Frontiers in immunology | 2018 |
Leishmania proteophosphoglycans regurgitated from infected sand flies accelerate dermal wound repair and exacerbate leishmaniasis via insulin-like growth factor 1-dependent signalling
E Giraud, T Lestinova, T Derrick, O Martin, RJ Dillon, P Volf, I Műller, PA Bates, ME Rogers, SM Beverley |
PLoS pathogens | 2018 |
Leishmania donovani reduces the levels of retinoic acid–synthesizing enzymes in infected macrophages and favoring its own survival
P Verma, AK Kureel, S Saini, S Prakash, S Kumari, SK Kottarath, SK Srivastava, M Bhat, AK Dinda, CP Thakur, S Sharma, AK Rai |
Parasitology Research | 2018 |
Role of IL-21 in host pathogenesis in experimental visceral leishmaniasis
R Khatonier, AM Khan, P Sarmah, GU Ahmed |
Journal of Parasitic Diseases | 2018 |
Cutaneous Leishmaniasis Due to Leishmania aethiopica
S van Henten, W Adriaensen, H Fikre, H Akuffo, E Diro, A Hailu, GV der Auwera, J van Griensven |
2018 |